Nishino et al. [36] endeavored to establish a two-antibody cocktail (from a panel of TTF1, NapA, CK5/6, and P40) for NSCLC subtyping with the aim of maximizing the capacity of cytology/small biopsy specimens in molecular studies. Here, TTF1 is linked to non-small cell lung carcinoma.